{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:30:41Z","timestamp":1794450641378,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60480-3","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:52:03Z","timestamp":1749030723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Molecular basis of the urate transporter URAT1 inhibition by gout drugs"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-7309","authenticated-orcid":false,"given":"Yang","family":"Suo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3660-3818","authenticated-orcid":false,"given":"Justin G.","family":"Fedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina","family":"Tsolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-1413","authenticated-orcid":false,"given":"Mario","family":"Borgnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-6041","authenticated-orcid":false,"given":"Wonpil","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-9921","authenticated-orcid":false,"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"60480_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin, M., Jacobsson, L. & Roddy, E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat. Rev. Rheumatol. 16, 380\u2013390 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"60480_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61616-z","volume":"14","author":"S Punjwani","year":"2024","unstructured":"Punjwani, S. et al. Burden of gout among different WHO regions, 1990\u20132019: estimates from the global burden of disease study. Sci. Rep. 14, 15953 (2024).","journal-title":"Sci. Rep."},{"key":"60480_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5114\/reum.2020.100140","volume":"58","author":"M Skoczy\u0144ska","year":"2020","unstructured":"Skoczy\u0144ska, M. et al. Pathophysiology of hyperuricemia and its clinical significance\u2013a narrative review. Reumatologia 58, 312\u2013323 (2020).","journal-title":"Reumatologia"},{"key":"60480_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du, L. et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct. Target. Ther. 9, 212 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"60480_CR5","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 357, j2376 (2017).","DOI":"10.1136\/bmj.j2376"},{"key":"60480_CR6","doi-asserted-by":"publisher","first-page":"1759720X2110166","DOI":"10.1177\/1759720X211016661","volume":"13","author":"G Sharma","year":"2021","unstructured":"Sharma, G., Dubey, A., Nolkha, N. & Singh, J. A. Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis. Ther. Adv. Musculoskelet. Dis. 13, 1759720X211016661 (2021).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"60480_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.114525","volume":"251","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Assessing the health risk of hyperuricemia in participants with persistent organic pollutants exposure-a systematic review and meta-analysis. Ecotoxicol. Environ. Saf. 251, 114525 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"60480_CR8","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1007\/s10067-022-06362-1","volume":"41","author":"T Gu","year":"2022","unstructured":"Gu, T. et al. A systematic review and meta-analysis of the hyperuricemia risk from certain metals. Clin. Rheumatol. 41, 3641\u20133660 (2022).","journal-title":"Clin. Rheumatol."},{"key":"60480_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto, A. et al. Molecular identification of a renal urate\u2013anion exchanger that regulates blood urate levels. Nature 417, 447\u2013452 (2002).","journal-title":"Nature"},{"key":"60480_CR10","doi-asserted-by":"publisher","first-page":"100852","DOI":"10.18632\/oncotarget.20135","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu, L., Shi, Y., Zhuang, S. & Liu, N. Recent advances on uric acid transporters. Oncotarget 8, 100852 (2017).","journal-title":"Oncotarget"},{"key":"60480_CR11","doi-asserted-by":"publisher","first-page":"174291","DOI":"10.1016\/j.ejphar.2021.174291","volume":"907","author":"D Song","year":"2021","unstructured":"Song, D., Zhao, X., Wang, F. & Wang, G. A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: current therapeutic options and potential applications. Eur. J. Pharmacol. 907, 174291 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"60480_CR12","doi-asserted-by":"publisher","first-page":"5738900","DOI":"10.1155\/2021\/5738900","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen, Y., You, R., Wang, K. & Wang, Y. Recent updates of natural and synthetic URAT1 inhibitors and novel screening methods. Evid.-Based Complement. Alternat. Med. 2021, 5738900 (2021).","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"60480_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-022-00243-y","volume":"159","author":"Y-L Nian","year":"2022","unstructured":"Nian, Y.-L. & You, C.-G. Susceptibility genes of hyperuricemia and gout. Hereditas 159, 30 (2022).","journal-title":"Hereditas"},{"key":"60480_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","volume":"59","author":"VF Azevedo","year":"2019","unstructured":"Azevedo, V. F., Kos, I. A., Vargas-Santos, A. B., Pinheiro, G. D. R. C. & Paiva, E. D. S. Benzbromarone in the treatment of gout. Adv. Rheumatol. 59, 37 (2019).","journal-title":"Adv. Rheumatol."},{"key":"60480_CR15","first-page":"651","volume":"22","author":"TTA Jansen","year":"2004","unstructured":"Jansen, T. T. A., Reinders, M., Van Roon, E. & Brouwers, J. Benzbromarone withdrawn from the European market: another case of\u201d absence of evidence is evidence of absence\u201d?[1]. Clin. Exp. Rheumatol. 22, 651 (2004).","journal-title":"Clin. Exp. Rheumatol."},{"key":"60480_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.12998\/wjcc.v7.i13.1717","volume":"7","author":"M-Y Zhang","year":"2019","unstructured":"Zhang, M.-Y., Niu, J.-Q., Wen, X.-Y. & Jin, Q.-L. Liver failure associated with benzbromarone: a case report and review of the literature. World J. Clin. Cases 7, 1717 (2019).","journal-title":"World J. Clin. Cases"},{"key":"60480_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40266-017-0461-y","volume":"34","author":"ED Deeks","year":"2017","unstructured":"Deeks, E. D. Lesinurad: a review in hyperuricaemia of gout. Drugs Aging 34, 401\u2013410 (2017).","journal-title":"Drugs Aging"},{"key":"60480_CR18","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1021\/acs.jmedchem.1c02057","volume":"65","author":"T Zhao","year":"2022","unstructured":"Zhao, T. et al. Discovery of novel bicyclic imidazolopyridine-containing human urate transporter 1 inhibitors as hypouricemic drug candidates with improved efficacy and favorable druggability. J. Med. Chem. 65, 4218\u20134237 (2022).","journal-title":"J. Med. Chem."},{"key":"60480_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41594-023-01017-4","volume":"30","author":"Y Suo","year":"2023","unstructured":"Suo, Y. et al. Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2. Nat. Struct. Mol. Biol. 30, 1001\u20131011 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60480_CR20","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41594-023-01123-3","volume":"30","author":"T Dou","year":"2023","unstructured":"Dou, T., Lian, T., Shu, S., He, Y. & Jiang, J. The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM. Nat. Struct. Mol. Biol. 30, 1794\u20131805 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60480_CR21","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41594-023-01039-y","volume":"30","author":"JL Parker","year":"2023","unstructured":"Parker, J. L., Kato, T., Kuteyi, G., Sitsel, O. & Newstead, S. Molecular basis for selective uptake and elimination of organic anions in the kidney by OAT1. Nat. Struct. Mol. Biol. 30, 1786\u20131793 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60480_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34284-8","volume":"13","author":"B Khanppnavar","year":"2022","unstructured":"Khanppnavar, B. et al. Structural basis of organic cation transporter-3 inhibition. Nat. Commun. 13, 6714 (2022).","journal-title":"Nat. Commun."},{"key":"60480_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","volume":"34","author":"Y Dai","year":"2024","unstructured":"Dai, Y. & Lee, C.-H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res. 34, 776\u2013787 (2024).","journal-title":"Cell Res."},{"key":"60480_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41586-021-04212-9","volume":"601","author":"Y Niu","year":"2022","unstructured":"Niu, Y. et al. Structural basis of inhibition of the human SGLT2\u2013MAP17 glucose transporter. Nature 601, 280\u2013284 (2022).","journal-title":"Nature"},{"key":"60480_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41586-023-06926-4","volume":"626","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. Transport and inhibition mechanisms of human VMAT2. Nature 626, 427\u2013434 (2024).","journal-title":"Nature"},{"key":"60480_CR26","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. Nature 632, 686\u2013694 (2024).","DOI":"10.1038\/s41586-024-07796-0"},{"key":"60480_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41594-019-0245-7","volume":"26","author":"NJ Wright","year":"2019","unstructured":"Wright, N. J. & Lee, S.-Y. Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat. Struct. Mol. Biol. 26, 599\u2013606 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"60480_CR28","doi-asserted-by":"crossref","unstructured":"He, J. et al. Structural basis for the transport and substrate selection of human urate transporter 1. Cell Rep. 43, 114628 (2024).","DOI":"10.1016\/j.celrep.2024.114628"},{"key":"60480_CR29","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1021\/acs.chemrev.0c00983","volume":"121","author":"D Drew","year":"2021","unstructured":"Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Structures and general transport mechanisms by the major facilitator superfamily (MFS). Chem. Rev. 121, 5289\u20135335 (2021).","journal-title":"Chem. Rev."},{"key":"60480_CR30","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1021\/jm049605m","volume":"47","author":"CW Locuson","year":"2004","unstructured":"Locuson, C. W., Suzuki, H., Rettie, A. E. & Jones, J. P. Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors. J. Med. Chem. 47, 6768\u20136776 (2004).","journal-title":"J. Med. Chem."},{"key":"60480_CR31","doi-asserted-by":"crossref","unstructured":"Wu, C. et al. Molecular mechanisms of uric acid transport by the native human URAT1 and its inhibition by anti-gout drugs. Cell Discov. 11, 33 (2024).","DOI":"10.1101\/2024.09.11.612394"},{"key":"60480_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neuron.2019.11.023","volume":"105","author":"Y Suo","year":"2020","unstructured":"Suo, Y. et al. Structural insights into electrophile irritant sensing by the human TRPA1 channel. Neuron 105, 882\u2013894.e885 (2020).","journal-title":"Neuron"},{"key":"60480_CR33","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1110\/ps.073002307","volume":"16","author":"AL Ringer","year":"2007","unstructured":"Ringer, A. L., Senenko, A. & Sherrill, C. D. Models of S\/\u03c0 interactions in protein structures: comparison of the H2S\u2013benzene complex with PDB data. Protein Sci. 16, 2216\u20132223 (2007).","journal-title":"Protein Sci."},{"key":"60480_CR34","doi-asserted-by":"crossref","unstructured":"Hu, T. et al. Transport and inhibition mechanisms of the human noradrenaline transporter. Nature 632, 930\u2013937 (2024).","DOI":"10.1038\/s41586-024-07638-z"},{"key":"60480_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp2211","volume":"10","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Mechanisms of sensory adaptation and inhibition of the cold and menthol receptor TRPM8. Sci. Adv. 10, eadp2211 (2024).","journal-title":"Sci. Adv."},{"key":"60480_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2843-2","volume":"587","author":"A Afek","year":"2020","unstructured":"Afek, A. et al. DNA mismatches reveal conformational penalties in protein\u2013DNA recognition. Nature 587, 291\u2013296 (2020).","journal-title":"Nature"},{"key":"60480_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature02632","volume":"430","author":"S-Y Lee","year":"2004","unstructured":"Lee, S.-Y. & MacKinnon, R. A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature 430, 232\u2013235 (2004).","journal-title":"Nature"},{"key":"60480_CR38","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/ci700257y","volume":"47","author":"T Cheng","year":"2007","unstructured":"Cheng, T. et al. Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J. Chem. Inf. Model. 47, 2140\u20132148 (2007).","journal-title":"J. Chem. Inf. Model."},{"key":"60480_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1124\/molpharm.122.000638","volume":"103","author":"J Gao","year":"2023","unstructured":"Gao, J. et al. A novel role of uricosuric agent benzbromarone in BK channel activation and reduction of airway smooth muscle contraction. Mol. Pharmacol. 103, 241\u2013254 (2023).","journal-title":"Mol. Pharmacol."},{"key":"60480_CR40","doi-asserted-by":"publisher","first-page":"16354","DOI":"10.1073\/pnas.1214596109","volume":"109","author":"F Huang","year":"2012","unstructured":"Huang, F. et al. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc. Natl Acad. Sci. 109, 16354\u201316359 (2012).","journal-title":"Proc. Natl Acad. Sci."},{"key":"60480_CR41","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/j.pain.0000000000000122","volume":"156","author":"Y Zheng","year":"2015","unstructured":"Zheng, Y. et al. Activation of peripheral KCNQ channels relieves gout pain. Pain 156, 1025\u20131035 (2015).","journal-title":"Pain"},{"key":"60480_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/molpharm.121.000256","volume":"100","author":"LWT Tang","year":"2021","unstructured":"Tang, L. W. T. et al. Differential reversible and irreversible interactions between benzbromarone and human cytochrome P450s 3A4 and 3A5. Mol. Pharmacol. 100, 224\u2013236 (2021).","journal-title":"Mol. Pharmacol."},{"key":"60480_CR43","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.3390\/ijms21197166","volume":"21","author":"EY Cotrina","year":"2020","unstructured":"Cotrina, E. Y. et al. Repurposing benzbromarone for familial amyloid polyneuropathy: a new transthyretin tetramer stabilizer. Int. J. Mol. Sci. 21, 7166 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"60480_CR44","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/aps.2013.97","volume":"34","author":"H-y Cai","year":"2013","unstructured":"Cai, H.-y et al. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db\/db mice. Acta Pharmacol. Sin. 34, 1397\u20131402 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"60480_CR45","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1021\/bi2004813","volume":"50","author":"TW Loo","year":"2011","unstructured":"Loo, T. W., Bartlett, M. C. & Clarke, D. M. Benzbromarone stabilizes \u0394F508 CFTR at the cell surface. Biochemistry 50, 4393\u20134395 (2011).","journal-title":"Biochemistry"},{"key":"60480_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bib\/bbn013","volume":"9","author":"K Katoh","year":"2008","unstructured":"Katoh, K. & Toh, H. Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinformatics 9, 286\u2013298 (2008).","journal-title":"Brief. Bioinformatics"},{"key":"60480_CR47","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. & Barton, G. J. Jalview version 2\u2014a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189\u20131191 (2009).","journal-title":"Bioinformatics"},{"key":"60480_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep34995","volume":"6","author":"PK Tan","year":"2016","unstructured":"Tan, P. K., Ostertag, T. M. & Miner, J. N. Mechanism of high-affinity inhibition of the human urate transporter URAT1. Sci. Rep. 6, 34995 (2016).","journal-title":"Sci. Rep."},{"key":"60480_CR49","doi-asserted-by":"crossref","unstructured":"Cornish-Bowden, A. Fundamentals of enzyme kinetics. (John Wiley & Sons, 2013).","DOI":"10.1016\/j.febslet.2013.06.009"},{"key":"60480_CR50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1017\/S1431927603445911","volume":"9","author":"DN Mastronarde","year":"2003","unstructured":"Mastronarde, D. N. SerialEM: a program for automated tilt series acquisition on Tecnai microscopes using prediction of specimen position. Microsc. Microanal. 9, 1182\u20131183 (2003).","journal-title":"Microsc. Microanal."},{"key":"60480_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83724","volume":"11","author":"J Zivanov","year":"2022","unstructured":"Zivanov, J. et al. A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0. Elife 11, e83724 (2022).","journal-title":"Elife"},{"key":"60480_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"60480_CR53","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"60480_CR54","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41586-022-05168-0","volume":"609","author":"NJ Wright","year":"2022","unstructured":"Wright, N. J. et al. Methotrexate recognition by the human reduced folate carrier SLC19A1. Nature 609, 1056\u20131062 (2022).","journal-title":"Nature"},{"key":"60480_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of coot. Acta Crystallogr. Sect. D: Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"60480_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. Sect. D: Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. Sect. D: Struct. Biol."},{"key":"60480_CR57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all\u2010atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"60480_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"60480_CR59","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"60480_CR60","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1021\/acs.jctc.8b01066","volume":"15","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. CHARMM-GUI membrane builder for complex biological membrane simulations with glycolipids and lipoglycans. J. Chem. Theory Comput. 15, 775\u2013786 (2019).","journal-title":"J. Chem. Theory Comput."},{"key":"60480_CR61","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"60480_CR62","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle Mesh Ewald - an N.Log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"60480_CR63","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"60480_CR64","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/ct5010406","volume":"11","author":"CW Hopkins","year":"2015","unstructured":"Hopkins, C. W., Le Grand, S., Walker, R. C. & Roitberg, A. E. Long-time-step molecular dynamics through hydrogen mass repartitioning. J. Chem. Theory Comput. 11, 1864\u20131874 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"60480_CR65","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1021\/acs.jcim.0c01360","volume":"61","author":"Y Gao","year":"2021","unstructured":"Gao, Y. et al. CHARMM-GUI supports hydrogen mass repartitioning and different protonation states of phosphates in lipopolysaccharides. J. Chem. Inf. Model. 61, 831\u2013839 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"60480_CR66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"60480_CR67","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","volume":"18","author":"CJ Dickson","year":"2022","unstructured":"Dickson, C. J., Walker, R. C. & Gould, I. R. Lipid21: complex lipid membrane simulations with AMBER. J. Chem. Theory Comput. 18, 1726\u20131736 (2022).","journal-title":"J. Chem. Theory Comput."},{"key":"60480_CR68","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case, D. A. et al. AmberTools. J. Chem. Inf. Model. 63, 6183\u20136191 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"60480_CR69","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. 3rd. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60480-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:03:33Z","timestamp":1749035013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60480-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60480"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60480-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.11.612563","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5178"}}